Clin2
NCT07267559Possibly a fitRecruiting

Daridorexant and emotion brain testing study

LearningCognitive FunctioningEmotional Processing

Treatments studied

Part of Brain & nervous system, Mental health clinical trials.

This study tests a medication called daridorexant, which affects the brain's sleep-wake system, to see how it influences emotions and thinking. You will take one dose and complete computer tasks that measure how you process emotional information.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
62 people
Ages
18 years to 40 years
Study type
Interventional

Who can take part

  • You are between 18 and 40 years old.
  • You do not have a sleep disorder or a mental health condition that requires treatment.
  • You do not have a medical condition like asthma, epilepsy, or liver disease that could make the study risky.
  • You are not pregnant, planning to become pregnant, or breastfeeding.
  • You are not taking any medications that affect brain function, such as sedatives or stimulants.
  • You are willing to avoid alcohol, grapefruit juice, and driving for 24 hours after the study visit.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06412315Recruiting
Brain scan study of emotion and a common antidepressant

This study uses a powerful MRI scanner to look at how a part of the brain called the amygdala responds to emotional tasks, and whether a common antidepressant called citalopram affects that response. It may help researchers understand how these treatments work for mental health conditions.

Oxford, Oxfordshire
NCT07213349Recruiting· Phase 2
Daridorexant for Alzheimer's prevention

This study tests whether daridorexant, a medication that helps improve sleep, can prevent Alzheimer's disease. If you have mild memory concerns but not dementia, this trial may help find out if better sleep can protect your brain.

Montreal, Quebec
NCT05924425Recruiting· Phase 4
Daridorexant for insomnia in early memory decline

This trial tests whether daridorexant can improve sleep in people who have mild cognitive impairment or early Alzheimer’s disease and struggle with insomnia. It may help by improving how long and how well you sleep, with monitoring of sleep patterns and memory-related measures.

Montpellier
NCT07843329Not yet recruiting· Phase 3
Daridorexant for insomnia to improve sleep and daytime function

This trial tests a new medicine, daridorexant, to see if it helps people with insomnia sleep better through the night and feel more alert during the day. The study will use a home device to check your sleep patterns before you join.

NCT07217912Recruiting· Phase 2
Study of daridorexant to prevent confusion after heart surgery

This trial tests whether a sleep medication called daridorexant can help prevent delirium (sudden confusion) in older adults after heart surgery. You must be 60 or older and having a specific type of heart operation.

Rochester, New York
NCT07847021Not yet recruiting
Daridorexant for adults with insomnia

This study follows adults with insomnia who are prescribed a new sleep medication called daridorexant. It aims to see how well the medication works in a real-world setting, and to monitor its safety and effects on sleep.

Chaohu, Anhui

Hear when a new Learning trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.